| Literature DB >> 33804304 |
Thelma M Mokgophi1, Nomakorinte Gcebe2, Folorunso Fasina3, Abiodun A Adesiyun1,4.
Abstract
The study determined the antimicrobial resistance profiles of Salmonella on chickens processed and retailed at outlets of the informal markets in Gauteng province, South Africa. The study also investigated the relationship of antimicrobial resistant Salmonella to the source and type of samples and their serotypes. Carcass swabs, cloacal swabs and carcass drips were randomly collected from each of 151 slaughtered chickens from six townships. Isolation and identification were performed using standard and polymerase chain reaction (PCR) methods. The disc diffusion method was used to determine the resistance of Salmonella isolates to 16 antimicrobial agents and PCR to determine their serovars. Ninety-eight (64.9%) of the 151 chickens were contaminated with Salmonella of which 94.9% (93/98) were resistant serovars. The frequency of antimicrobial resistance of Salmonella isolates was high to erythromycin (94.9%) and spectinomycin (82.7%) but was low to ciprofloxacin (1.0%) and norfloxacin (1.0%) (p < 0.05). All 170 isolates of Salmonella tested exhibited resistance to one or more antimicrobial agents and the frequency varied significantly (p < 0.05) across the townships, the type of samples and the serovars. The prevalence of multidrug resistance (MDR) in Salmonella was 81.8% (139/170). Our findings pose zoonotic, food safety and therapeutic risks to workers and consumers of undercooked, contaminated chickens from these outlets.Entities:
Keywords: Gauteng province; Salmonella in chickens; South Africa; antimicrobial resistance profiles; chicken
Year: 2021 PMID: 33804304 PMCID: PMC8000370 DOI: 10.3390/pathogens10030273
Source DB: PubMed Journal: Pathogens ISSN: 2076-0817
Prevalence of resistant Salmonella in chickens sampled from the informal market in Gauteng province, South Africa.
| No. (%) of Resistant | ||||||||
|---|---|---|---|---|---|---|---|---|
| Atteridgeville | Garanguwa | Tembisa/Modise | Alexandra | Germiston | Soweto | Total | ||
| Antimicrobial Agent | ( | ( | ( | ( | ( | ( | ( | |
| Erythromycin (E) | 4 (100.0) | 3 (60.0) | 1 (100.0) | 10 (76.9) | 20 (100.0) | 55 (100.0) | <0.001 | 93 (94.9) |
| Oxytetracycline (OXT) | 2 (50.0) | 0 (0.0) | 0 (0.0) | 5 (38.5) | 11 (55.0) | 46 (83.6) | <0.001 | 64 (65.3) |
| Chloramphenicol (C) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (3.6) | 0.902 | 2 (2.0) |
| Kanamycin (K) | 1 (25.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.8) | 0.044 | 2 (2.0) |
| Nalidixic acid (NA) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (1.8) | 0.978 | 1 (1.0) |
| Streptomycin (S) | 3 (75.0) | 0 (0.0) | 0 (0.0) | 6 (46.2) | 15 (75.0) | 49 (89.1) | <0.001 | 73 (74.5) |
| Spectinomycin (SPE) | 4 (100.0) | 0 (0.0) | 0 (0.0) | 7 (53.8) | 19 (95.0) | 51 (87.9) | <0.001 | 81 (82.7) |
| Ciprofloxacin (CIP) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (5.0) | 0 (0.0) | 0.558 | 1 (1.0) |
| Ampicillin (AMP) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (10.0) | 3 (5.5) | 0.815 | 5 (5.1) |
| Cefotaxime (CET) | 1 (25.0) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 6 (30.0) | 7 (12.7) | 0.351 | 15 (15.3) |
| Doxycycline (DO) | 2 (50.0) | 0 (0.0) | 0 (0.0) | 4 (30.8) | 10 (50.0) | 42 (76.4) | 0.001 | 58 (59.2) |
| Gentamycin (CN) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (10.0) | 0 (0.0) | 0.158 | 2 (2.0) |
| Amoxicillin-clavulanic acid (AMOX) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 1 (5.0) | 2 (3.6) | 0.968 | 4 (4.1) |
| Sulfamethoxazole-trimethoprim (SXT) | 2 (50.0) | 0 (0.0) | 0 (0.0) | 4 (30.8) | 1 (5.0) | 2 (3.6) | 0.003 | 9 (9.2) |
| Ceftazidime (CAZ) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (10.0) | 1 (1.8) | 0.513 | 3 (3.1) |
| Norfloxacin (NOR) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (7.7) | 0 (0.0) | 0 (0.0) | 0.252 | 1 (1.0) |
| <0.001 | <0.001 | 0.382 | <0.001 | <0.001 | <0.001 | |||
a Isolates of Salmonella originally recovered from 151 chickens distributed across six townships comprising Atteridgeville (23), Garanguwa (18), Tembisa/Modise (10), Alexandra (20), Germiston (20), and Soweto (60), respectively as reported earlier by Mokgophi et al. [32]. b For a total of 98 Salmonella-positive chickens, the chicken-specific frequency of antimicrobial resistant Salmonella recovered was determined.
Prevalence of antimicrobial resistance in Salmonella isolates by type of sample.
| No. (%) of Resistant | ||||
|---|---|---|---|---|
| Carcass Swab | Cloacal Swab | Carcass Drip | ||
| Antimicrobial Agent | ( | ( | ( | |
| Erythromycin (E) | 54 (100.0) | 56 (100.0) | 60 (100.0) | NA |
| Oxytetracycline (OXT) | 37 (68.5) | 44 (78.6) | 46 (76.7) | 0.436 |
| Chloramphenicol (C) | 0 (0.0) | 0 (0.0) | 2 (3.3) | 0.156 |
| Kanamycin (K) | 0 (0.0) | 4 (7.1) | 1 (1.7) | 0.066 |
| Nalidixic acid (NA) | 0 (0.0) | 1 (1.8) | 1 (1.7) | 0.623 |
| Streptomycin (S) | 34 (63.0) | 48 (85.7) | 54 (90.0) | <0.001 |
| Spectinomycin (SPE) | 46 (85.2) | 51 (91.1) | 54 (90.0) | 0.580 |
| Ciprofloxacin (CIP) | 0 (0.0) | 1 (1.8) | 0 (0.0) | 0.359 |
| Ampicillin (AMP) | 0 (0.0) | 5 (8.9) | 3 (5.0) | 0.086 |
| Cefotaxime (CET) | 2 (3.7) | 13 (23.2) | 9 (15.0) | 0.0130 |
| Doxycycline (DO) | 35 (64.8) | 12 (21.4) | 42 (70.0) | <0.001 |
| Gentamycin (CN) | 0 (0.0) | 3 (5.4) | 3 (5.0) | 0.234 |
| Amoxicillin-clavulanic acid (AMOX) | 2 (3.7) | 4 (7.1) | 1 (1.7) | 0.327 |
| Sulfamethoxazole-trimethoprim (SXT) | 0 (0.0) | 5 (8.9) | 6 (10.0) | 0.063 |
| Ceftazidime (CAZ) | 1 (1.9) | 4 (7.1) | 1 (1.7) | 0.201 |
| Norfloxacin (NOR) | 0 (0.0) | 1 (1.8) | 1 (1.7) | 0.623 |
| <0.001 | <0.001 | <0.001 | ||
a A total of 170 isolates of Salmonella recovered from carcass swabs (n = 54), cloacal swabs (n = 56), and carcass drips (n = 60), based on their serovars were tested for their resistance to antimicrobial agents to determine sample type-specific frequency of resistance; NA: Not applicable.
Frequency of resistant Salmonella isolates belonging to different serovars isolated from chickens in the informal market in Gauteng province, South Africa.
| No. (%) of | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bovismorbificans | Hadar | Dublin | Enteritidis | Mbandaka | Saintpaul | Thompson | Infantis | Agona | Total | ||
| Antimicrobial Agents | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | |
| Erythromycin | 41 (100.0) | 18 (100.0) | 13 (100.0) | 11 (100.0) | 9 (100.0) | 6 (100.0) | 2 (100.0) | 2 (100.0) | 1 (100.0) | NA | 103 (100.0) |
| Oxytetracycline | 38 (92.7) | 11 (61.1) | 10 (76.9) | 9 (81.8) | 7 (77.8) | 4 (66.7) | 1 (50.0) | 1 (50.0) | 1 (100.0) | 0.188 | 84 (81.6) |
| Chloramphenicol | 0 (0.0) | 1 (5.6) | 0 (0.0) | 1 (9.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.686 | 2 (1.9) |
| Kanamycin | 1 (2.4) | 1 (5.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.976 | 2 (1.9) |
| Nalidixic acid | 0 (0.0) | 1 (5.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.782 | 1 (1.0) |
| Streptomycin | 38 (92.7) | 15 (83.3) | 11 (84.6) | 9 (81.8) | 8 (88.9) | 2 (33.3) | 1 (50.0) | 1 (50.0) | 1 (100.0) | 0.029 | 83.5 |
| Spectinomycin | 39 (95.1) | 16 (88.9) | 12 (92.3) | 9 (81.8) | 7 (77.8) | 6 (100.0) | 1 (50.0) | 1 (50.0) | 1 (100.0) | 0.213 | 92 (89.3) |
| Ciprofloxacin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | NA | 0 |
| Ampicillin | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (9.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.391 | 1 (1.0) |
| Cefotaxime | 1 (2.4) | 3 (16.7) | 3 (23.1) | 2 (18.2) | 2 (22.2) | 0 (0.0) | 1 (50.0) | 0 (0.0) | 0 (0.0) | 0.205 | 12(11.7) |
| Doxycycline | 34 (82.9) | 13 (7 | 9 (69.2) | 9 (81.8) | 5 (55.6) | 4 (66.7) | 0 (0.0) | 1 (50.0) | 1 (100.0) | 0.227 | 76 (73.8) |
| Gentamycin | 2 (4.9) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.929 | 2 (1.9) |
| AmoxycillinClavulanic acid | 3 (7.3) | 0 (0.0) | 0 (0.0) | 2 (18.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.497 | 5 (4.9) |
| Sulfamethoxazole-trimethoprim | 2 (4.9) | 1 (5.6) | 0 (0.0) | 1 (9.1) | 1 (11.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.965 | 5 (4.9) |
| Ceftazidime | 1 (2.4) | 0 (0.0) | 0 (0.0) | 1 (9.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.856 | 2 (1.9) |
| Norfloxacin | 1 (2.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.992 | 1 (1.0) |
| <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.220 | 0.220 | 0.382 | |||
a Among all the 41 isolates that belonged to serovar Bovismorbificans, resistance was exhibited to 12 different antimicrobial agents tested (i.e., 75.0%, 12/16) by at least one isolate.
Resistance patterns exhibited by Salmonella isolates recovered by types of samples collected.
| No. (%) of Isolates of | ||||
|---|---|---|---|---|
| No. of Antimicrobial | Carcass Swabs | Cloacal Swabs | Carcass Drips | |
| Resistance Pattern a | Agents in Pattern | ( | ( | ( |
| E-OXT-S-SPE-DO | 5 | 23 (42.6) | 23 (41.1) | 26 (43.3) |
| E-SPE | 2 | 6 (11.1) | 0 (0.0) | 1 (1.7) |
| E-OXT-SPE-DO | 4 | 6 (11.1) | 0 (0.0) | 0 (0.0) |
| E | 1 | 6 (11.1) | 2 (3.6) | 6 (10.0) |
| E-OXT-S-SPE-D0-AMOX | 6 | 2 (3.7) | 0 (0.0) | 0 (0.0) |
| E-S-SPE-DO | 4 | 2 (3.7) | 1 (1.8) | 0 (0.0) |
| E-OXT-S-SPE | 4 | 2 (3.7) | 0 (0.0) | 0 (0.0) |
| E-OXT-S-SPE-CET-DO | 6 | 0 (0.0) | 5 (8.9) | 3 (5.0) |
| E-OXT-S-DO | 4 | 0 (0.0) | 3 (5.4) | 1 (1.7) |
| E-SPE-CET | 3 | 0 (0.0) | 2 (3.6) | 0 (0.0) |
| E-S-SPE-CET | 4 | 1 (1.9) | 2 (3.6) | 0 (0.0) |
| E-S-SPE | 3 | 2 (3.7) | 2 (3.6) | 3 (5.0) |
| E-OXT-S-SPE-DO-CN | 6 | 0 (0.0) | 2 (3.6) | 0 (0.0) |
| E-OXT-K-S-SPE-DO | 6 | 0 (0.0) | 2 (3.6) | 0 (0.0) |
| E-OXT-S-SPE | 4 | 0 (0.0) | 0 (0.0) | 3 (5.0) |
| E-OXT-S-SPE-DO-SXT-NOR | 7 | 0 (0.0) | 0 (0.0) | 2 (3.3) |
| E-0XT-S-SPE-DO-SXT | 6 | 0 (0.0) | 1 (1.8) | 2 (3.3) |
| E-SPE-DO | 3 | 1 (1.9) | 0 (0.0) | 1 (1.7) |
| E-OXT-S | 3 | 1 (1.9) | 0 (0.0) | 0 (0.0) |
| E-OXT-DO | 3 | 1 (1.9) | 0 (0.0) | 1 (1.7) |
| E-OXT-S-SPE-CET-DO-CEFT | 7 | 1 (1.9) | 0 (0.0) | 0 (0.0) |
| E-OXT-S-SPE-CET-D0-SXT | 7 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-OXT-K-S-SPE-DO-SXT | 7 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-OXT-K-S-SPE-AMP-DO-SXT | 8 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-SPE-CET-AMOX-CEFT | 5 | 0 (0.0) | 2 (3.6) | 0 (0.0) |
| E-SPE-AMP-CET-CN-CEFT | 6 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-OXT-S-SPE-AMP-DO-AMOX-CEFT | 8 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-OXT-S-SPE-AMP-CET-DO-AMOX-CEFT | 9 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-OXT-S-SPE-DO-SXT | 6 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-OXT-S-SPE-AMP-DO-AMOX | 7 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-OXT-K-S-SPE-DO | 6 | 0 (0.0) | 1 (1.8) | 0 (0.0) |
| E-OXT-S-SPE-DO-AMOX-SXT | 7 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
| E-S | 2 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
| E-S-SPE-AMP-CET-CN-CEFT | 7 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
| E-S-SPE-AMP-CET-CN | 6 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
| E-S-SPE-CET-DO | 5 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
| E-OXT-S-SPE-SXT | 5 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
| E-OXT-C--S-SPE-DO | 6 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
| E-OXT-S-SPE-DO-CN | 6 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
| E-OXT-C-K-S-SPE-CET-DO-SXT | 10 | 0 (0.0) | 0 (0.0) | 1 (1.7) |
a E—erythromycin, OXT—tetracycline, C—chloramphenicol, K—kanamycin, NA—nalidixic acid, S—streptomycin, SPE—spectinomycin, CIP—ciprofloxacin, AMP—ampicillin, CET—cefotaxime, DO—doxycycline, CN—gentamycin, AMOX—amoxicillin-clavulanic acid, SXT—sulfamethoxazole-trimethoprim, CAZ—ceftazidime, NOR—norfloxacin.
Primers used for molecular serotyping [70].
| Reaction 1 (STM) (Five-Plex) | Product Size (bp) | |
|---|---|---|
| 187 | ||
| 171 | ||
| 137 | ||
| 114 | ||
| 93 | ||
|
| ||
| 301 | ||
| 262 | ||
| 220 | ||
| 181 | ||
| 124 | ||
|
| ||
| 225 | ||
|
| ||
| 101 | ||
Classes and concentrations of antimicrobial agents used in the study.
| Class of Antimicrobial Agents | Type of Antimicrobial Agents Used | Concentration (µg) |
|---|---|---|
| Aminoglycosides | Spectinomycin (SPE) | 100 |
| Streptomycin (S) | 10 | |
| Kanamycin (K) | 30 | |
| Gentamycin (CN) | 10 | |
| Beta lactams | Ampicillin (AMP) | 10 |
| Amoxicillin-clavulanic acid (AMOX) | 30 | |
| Cephalosporin | Ceftazidime (CAZ) | 30 |
| Cefotaxime (CET) | 30 | |
| Fluoroquinolones | Nalidixic acid (NA) | 30 |
| Norfloxacin (NOR) | 10 | |
| Ciprofloxacin (CIP) | 5 | |
| Macrolides | Erythromycin (E) | 15 |
| Phenicols | Chloramphenicol (C) | 30 |
| Sulphonamides | Sulfamethoxazole-trimethoprim (SXT) | 23.75/1.25 |
| Tetracyclines | Oxytetracycline (OXT) | 30 |
| Doxycycline (DO) | 30 |